Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02768038

Intestinal Microbiome and Chronic Inflammatory Bowel Disease

The Role of Intestinal Microbiome ih the Pathogenesis and Course of Chronic Inflammatory Bowel Diseases

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Turku University Hospital · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

Detailed description

IBD patients to whom colonoscopy is performed will be recruited. Mucosal specimens from large intestine and terminal ileum will be collected as well as stool specimens. The microbiota will be analyzed at the microbiology laboratory and the results will be correlated with endoscopical, laboratory and histopathological findings.

Conditions

Interventions

TypeNameDescription
OTHERObservationalBlood, stool ja biopsy specimens

Timeline

Start date
2016-05-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2016-05-11
Last updated
2025-05-01

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02768038. Inclusion in this directory is not an endorsement.